INZY: Prakiraan wutah bathi saben saham kanggo taun ngarep Inozyme Pharma
Inozyme Pharma, Inc. (INZY) develops advanced enzyme therapies to combat tissue mineralization pathologies. The business is currently spending capital on research without stable cash inflows. The projected net profit trend indicates that the current level is around 39.90. In the long term, patents for treating rare genetic calcification diseases will allow the company to monetize its developments through drug exclusivity.
Rincian analitis lan laporan data perusahaan Inozyme (INZY)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- informasi kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Inozyme Pharma, Inc.|INZY - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas inozyme.com|INZY - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Inozyme|INZY - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Inozyme Pharma|Rasio cepet inozyme.com
- data bathi resik lan rasio valuasi:
INZY - Asil keuangan resik|Bathi sing dikarepake Inozyme Pharma, Inc.|INZY - Pangali rega marang bathi|Rega marang bathi mangsa ngarep Inozyme Pharma Inc.|INZY - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Inozyme Pharma, Inc.|INZY - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Inozyme Pharma|INZY - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan inozyme.com|INZY - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Inozyme Pharma, Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Pambiji fundamental perusahaan:INZY, Inozyme Pharma Inc.
Amid intense competition in rare disease therapy, the success of Inozyme Pharma, Inc. (INZY) depends on clinical trial outcomes and market positioning. This metric aggregates revised analyst earnings forecasts for the coming year, reflecting market expectations for drug commercialization. Positive momentum in the growth assessment of next year's EPS confirms the business's fundamental resilience, whereas sharp declines signal critical risks.
Analisis perusahaan pesaing
VRTX (Vertex) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep ALNY (Alnylam)|Prakiraan wutah bathi saben saham kanggo taun ngarep INSM (Insmed)|UTHR (United Therapeutics Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|BGM Group Ltd - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep COGT (Cogent Biosciences)|XERS: Prakiraan wutah bathi kanggo taun ngarep|Keros Therapeutics Inc (KROS) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Arcturus Pharma|ETON: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep kamada.com (KMDA)|Prakiraan wutah bathi saben saham kanggo taun ngarep Fulcrum Therapeutics FULC|Prakiraan wutah bathi kanggo taun ngarep ABEO (Abeona Therapeutics, Inc.)|Prakiraan wutah bathi kanggo taun ngarep Mereo BioPharma MREO|PLX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PLRX|Applied Therapeutics (APLT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Rein Therapeutics Inc (RNTX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Gelteq Limited|AYTU (Aytu BioPharma) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Chemomab Therapeutics Ltd (CMMB)|SRXH (SRx Health Solutions) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Polyrizon Ltd PLRZ|Dinamika bathi saben saham sing diarepake ing taun ngarep AEZS|CYTH: Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep
